000 | 01440nam a2200169Ia 4500 | ||
---|---|---|---|
008 | 140223b2008 xxu||||| |||| 00| 0 eng d | ||
020 |
_a9783527318773 _c0.00 |
||
082 |
_a615.7 _bTOB |
||
100 |
_aTobin, John J. _919337 |
||
245 | _aMedical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices | ||
260 |
_aNew York _bWiley-VCH _c2008 |
||
300 | _a283p | ||
500 | _a"This book is an excellent reference for people starting out in regulatory affairs, as well as those working within the area whose product portfolio is adapting and changing.-"Microbiology Today, May 2009.Written in a clear and concise style by experienced authors, this book covers regulatory affairs in all major global markets for pharmaceuticals and medical devices.Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics include CDER, CBER and marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/Manufacturing Practices.The book covers everything pharmacologists, bioengineers, pharma engineers, students in pharmacy and those working in the pharmaceutical industry need to know about medical regulatory affairs. | ||
700 |
_aWalsh, Gary _916733 |
||
942 |
_2ddc _cLB _k615.7 _mTOB |
||
995 |
_aPharmacy Reference _eP0006149 _j615.7 _yP0006149 |
||
999 |
_c15799 _d15799 |